tiprankstipranks
Advertisement
Advertisement

HK:2162 Stock Latest News

Keymed Biosciences Details Gain and Capital Plans From Ouro Medicines Stake Disposal
Company AnnouncementsKeymed Biosciences Details Gain and Capital Plans From Ouro Medicines Stake Disposal
13d ago
2162
Keymed Biosciences boosts revenue on Kangyueda push while deepening R&D pipeline
PremiumCompany Announcements
Keymed Biosciences boosts revenue on Kangyueda push while deepening R&D pipeline
1M ago
2162
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
PremiumMarket News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
1M ago
GSK
GILD
Keymed Biosciences to Realize Up to US$320 Million From Ouro Medicines Exit
PremiumCompany Announcements
Keymed Biosciences to Realize Up to US$320 Million From Ouro Medicines Exit
1M ago
2162
Keymed Biosciences Sets March 26 Board Meeting to Approve 2025 Results and Consider Final Dividend
PremiumCompany Announcements
Keymed Biosciences Sets March 26 Board Meeting to Approve 2025 Results and Consider Final Dividend
1M ago
2162
Keymed Gains US$45 Million Milestone as AstraZeneca Starts Phase III Trial of Core Cancer Drug
PremiumCompany AnnouncementsKeymed Gains US$45 Million Milestone as AstraZeneca Starts Phase III Trial of Core Cancer Drug
2M ago
2162
Keymed Biosciences’ Strategic Positioning and Stapokibart’s Market Potential in Biotech Sector
Premium
Ratings
Keymed Biosciences’ Strategic Positioning and Stapokibart’s Market Potential in Biotech Sector
6M ago
Keymed Biosciences Reports Strong Revenue Growth Amid Leadership Change
Premium
Company Announcements
Keymed Biosciences Reports Strong Revenue Growth Amid Leadership Change
8M ago
2162
Keymed Biosciences Schedules Board Meeting to Review Interim Results
PremiumCompany Announcements
Keymed Biosciences Schedules Board Meeting to Review Interim Results
9M ago
2162
Keymed Biosciences Announces Successful AGM Resolutions
PremiumCompany Announcements
Keymed Biosciences Announces Successful AGM Resolutions
10M ago
2162
Keymed Biosciences Completes Share Placement and Subscription, Raising HK$853.77 Million
PremiumCompany Announcements
Keymed Biosciences Completes Share Placement and Subscription, Raising HK$853.77 Million
10M ago
2162
Keymed Biosciences Announces Share Placement and Subscription to Raise HK$853.77 Million
PremiumCompany Announcements
Keymed Biosciences Announces Share Placement and Subscription to Raise HK$853.77 Million
11M ago
2162
Keymed Biosciences Announces 2025 Annual General Meeting and Key Resolutions
PremiumCompany AnnouncementsKeymed Biosciences Announces 2025 Annual General Meeting and Key Resolutions
12M ago
2162
Keymed Biosciences to Review Annual Results and Dividend
Premium
Company Announcements
Keymed Biosciences to Review Annual Results and Dividend
1y ago
2162
Keymed Biosciences Gains Approval for Stapokibart in Allergic Rhinitis Treatment
Premium
Company Announcements
Keymed Biosciences Gains Approval for Stapokibart in Allergic Rhinitis Treatment
1y ago
2162
Keymed Biosciences Licenses CM355 to Prolium for Global Development
PremiumCompany Announcements
Keymed Biosciences Licenses CM355 to Prolium for Global Development
1y ago
2162
Keymed Biosciences Secures Licensing Deal for CM313
PremiumCompany Announcements
Keymed Biosciences Secures Licensing Deal for CM313
1y ago
2162
Keymed Biosciences Gains NMPA Approval for Stapokibart
PremiumCompany Announcements
Keymed Biosciences Gains NMPA Approval for Stapokibart
1y ago
2162
Keymed Biosciences Relocates Hong Kong Headquarters
PremiumCompany Announcements
Keymed Biosciences Relocates Hong Kong Headquarters
1y ago
2162
Keymed Biosciences’ CM336 Shows Promise in Myeloma Study
PremiumCompany AnnouncementsKeymed Biosciences’ CM336 Shows Promise in Myeloma Study
1y ago
2162
Keymed Biosciences Expands Global Reach with CM336 Deal
Premium
Company Announcements
Keymed Biosciences Expands Global Reach with CM336 Deal
1y ago
2162
Keymed Biosciences’ Stapokibart Wins Approval in China
Premium
Company Announcements
Keymed Biosciences’ Stapokibart Wins Approval in China
2y ago
2162

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >